Ovid Therapeutics Inc (NASDAQ:OVID)
| 3.22 Delayed Data As of Dec 01 |  +0.245 / +8.24%Today’s Change | 1.62 Today|||52-Week Range 4.14 | +73.12% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $227.6M |
Company Description
Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.
Contact Information
Ovid Therapeutics, Inc. 441 9th Avenue New York New York 10001 |
Employees
Shareholders
| Other institutional | 47.43% |
| Individual stakeholders | 30.84% |
| Mutual fund holders | 13.11% |
Top Executives
| Jeremy Max Levin | Chairman, President & Chief Executive Officer |
| Jason Tardio | Chief Operating Officer |
| Jeffrey A. Rona | Chief Financial & Business Officer |
| Julia Tsai | Senior VP-Clinical Development & Medical Affairs |
| Manoj Malhotra | Chief Medical Officer |
